SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-000224
Filing Date
2024-01-04
Accepted
2024-01-04 16:07:39
Documents
2
Period of Report
2024-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4522
2 POA ggolumbeskipoa2019.txt EX-24 2073
  Complete submission text file 0001562180-24-000224.txt   8011
Mailing Address C/O CELGENE CORP. 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Golumbeski George (Reporting) CIK: 0001586660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 24511874

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)